BRIEF published on 04/10/2025 at 19:05, 1 year 4 months ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 4 months ago Informations privilégiées / Autres communiqués TME Pharma augmente les ressources allouées au contrat de liquidité confié à Invest Securities pour renforcer la trésorerie. Détails des ressources disponibles après l'augmentation Contrat De Liquidité INVEST SECURITIES Trésorerie Ressources TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 4 months ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 5 months ago TME Pharma présente sa feuille de route stratégique et ses initiatives pour 2025 Biotechnologie Partenariats Stratégiques Thérapie Contre Le Cancer Découverte De Médicaments NOX-A12
BRIEF published on 02/17/2025 at 08:05, 1 year 5 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 5 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 6 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
BRIEF published on 01/29/2025 at 08:05, 1 year 6 months ago TME Pharma et aimed analytics : Partenariat innovant pour la découverte de médicaments par l'IA Biotechnologie Partenariat Intelligence Artificielle Cancer Médicaments
PRESS RELEASE published on 01/29/2025 at 08:00, 1 year 6 months ago Inside Information / Other news releases TME Pharma collaborates with aimed analytics for AI-driven drug discovery, strengthening capabilities for strategic transactions. The partnership utilizes AI to accelerate drug development and optimize existing therapies Strategic Partnerships Cancer Treatment TME Pharma AI-driven Drug Discovery Aimed Analytics
PRESS RELEASE published on 01/29/2025 at 08:00, 1 year 6 months ago Informations privilégiées / Autres communiqués TME Pharma annonce une collaboration avec aimed analytics pour optimiser la découverte de médicaments par IA, renforçant son profil stratégique Collaboration IA Médicaments TME Pharma Aimed Analytics
Published on 08/14/2026 at 00:15, 1 hour 15 minutes ago Corporate Update - QCM Property Exploration Update
Published on 08/13/2026 at 22:38, 2 hours 52 minutes ago Predictiv AI Announces Debt Settlement and Provides Additional Details of Previously Announced Consulting Agreement With Aktien Media Inc.
Published on 08/13/2026 at 19:55, 5 hours 35 minutes ago NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 7 hours 35 minutes ago Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 10 hours 59 minutes ago Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 23:20, 2 hours 10 minutes ago DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet
Published on 08/13/2026 at 22:56, 2 hours 34 minutes ago BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE
Published on 08/13/2026 at 18:17, 7 hours 13 minutes ago EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 7 hours 30 minutes ago Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 18:00, 7 hours 30 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 7 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 7 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 7 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 7 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
